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Abstract
Background—As both micronutrients and antimicrobial peptides protect against diarrhoea, we
looked for an effect on intestinal antimicrobial peptide gene expression during a randomised
controlled trial of multiple micronutrient (MM) supplementation.
Methods—Consenting adults (n=287) in Lusaka, Zambia were randomised to a daily MM
supplement or placebo, and followed for 3.3 years with a cross-over after 2 years. Intestinal
biopsies were taken at annual intervals and mRNA of the intestinal antimicrobial peptides HD5,
HD6, hBD1, hBD2 and LL-37 were quantified by real time RT-PCR. Samples were also taken
during diarrhoea episodes and after convalescence.
Results—There was no effect overall of treatment allocation. However in malnourished adults
(body mass index <18.5kg/m2), HD5 mRNA was increased by 0.8 log transcripts/μg total RNA in
MM recipients compared to placebo (P=0.007). During diarrhoea, HD5 expression was reduced by
0.8 log transcripts in placebo recipients (P=0.02) but not in MM recipients nor after the cross-over.
Correlations between HD5 and nutritional status were found which were sex-specific but not
explained by serum leptin or adiponectin concentrations.
Conclusion—Micronutrient supplementation was associated with up-regulation of HD5 only in
malnourished adults. Interactions between antimicrobial gene expression and nutritional status
may help explain increased infection risk in malnutrition.
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Introduction
Diarrhoeal disease remains a major cause of morbidity and mortality in children, especially
malnourished and HIV-infected children, in tropical countries [1,2,3]. Despite impressive
roll-out of anti-retroviral therapy in many parts of Africa, including Zambia [4], HIV
infected adults and children continue to present with gastrointestinal opportunistic
infections, many of which are still difficult to treat. Reducing morbidity and mortality from
gastrointestinal infections presents a major challenge because significant improvements in
water supply and sanitation will require economic transformation of large areas of Africa
and Asia,. Understanding mucosal defence mechanisms in the intestine may lead to
development of novel strategies to augment resistance to intestinal infection.
Evidence from a considerable body of randomised controlled trials indicates that
micronutrient supplementation can prevent diarrhoea in children [5,6] (though not in all
trials [7]) and in HIV infected adults too, though data are fewer [8,9]. There is also evidence
that zinc supplementation reduces morbidity and mortality from diarrhoeal disease when
started during the episode [6, 10]. However, it is not at all clear how this protective effect is
mediated. Evidence of an effect on cell mediated immunity is inconclusive [11], and some
promising evidence has been discredited [12], but there is some evidence that in HIV
infected adults micronutrients can increase CD4 count [13]. Very little evidence, if any,
exists on the impact of nutritional interventions on innate immunity and host defence
mechanisms. In previous work we found that gene expression of α-defensins is lower in
adults living in Misisi, Lusaka, than in London, UK [14], and we postulated that this may
reflect a nutritional deficiency. In preliminary work for this trial, between 10 and 20% of
adults in this population were shown to have low blood concentrations of vitamin A, folate
or zinc, and 4 placebo recipients developed pellagra during the course of the trial, so this
population appears to have several borderline micronutrient deficiencies.
Mucosal defence in the intestine relies on physical and chemical barriers, as well as
regulated pathways of innate and adaptive immunity. A critical component of these barriers
is the layer of antimicrobial molecules secreted onto the mucosa, including defensins,
cathelicidin LL-37, and other cationic peptides and proteins such as lysozyme [15,16,17]. In
the present study we set out to determine the extent to which antimicrobial peptide host
defence mechanisms are dependent on micronutrient status, by conducting a randomised
placebo-controlled trial of daily multiple micronutrient supplementation [18]. Small
intestinal biopsies were collected annually in a scheduled programme over 3 years and 4
months (3.3 years) and analysed for gene expression and histologically. As there is evidence
that intestinal infection suppresses expression of antimicrobial peptides [19,20] and that
enterotoxins can do the same in vitro [21], we also collected biopsies during diarrhoeal
episodes and after convalescence to determine if micronutrient supplementation affects
antimicrobial gene expression during the dynamic challenge of active infection.
Study design and methods
The design of the randomised controlled trial during which these intestinal biopsy samples
were collected has been reported in detail elsewhere, together with data on the effect of the
MM supplement on diarrhoeal disease, CD4 count, and mortality [18]. Briefly, 500 adults
resident in one section of Misisi compound, Lusaka, Zambia, were recruited into a
randomised controlled trial of micronutrient supplementation compared to placebo and gave
consent. The composition of the multiple micronutrient (MM) supplement was designed to
achieve replenishment of 15 nutrients at physiological levels [18]. Ethical approval was
obtained from the Research Ethics Committees of the University of Zambia and the London
School of Hygiene and Tropical Medicine. The trial was registered as ISRCTN31173864.
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Small intestinal biopsies were collected from the second or third part of the duodenum by an
experienced endoscopist (PK) using Pentax fibre-optic FG29W gastroscopes under sedation
with midazolam (usual dose 5mg). Two sets of biopsies were collected.
In the first set, participants were invited to come at random for endoscopy in a rolling
programme so that biopsies were collected throughout the year (these will be referred to as
‘scheduled biopsies’). These participants were subsequently invited at annual intervals so
that each participant was biopsied in approximately the same month of each year to control
for seasonal effects [22]. Endoscopies were postponed or cancelled if the participants had
experienced diarrhoea or had taken antibiotics or non-steroidal anti-inflammatory drugs
(NSAIDs) within one month before the scheduled endoscopy, or were pregnant or lactating.
As the trial lasted 3 years and 4 months, participants underwent endoscopy on between one
and four occasions.
In the second set, participants who experienced an episode of diarrhoea lasting for 3 days or
more were invited to undergo endoscopy during that episode and when free of diarrhoea
(referred to as ‘diarrhoea biopsies’). Sometimes, by chance, a scheduled biopsy had been
taken within a month of the onset of the diarrhoeal illness, but more commonly a
convalescent biopsy had to be taken a month after resolution of the illness (both of these
together are referred to as ‘convalescent biopsies’). The subsequent course of this illness
was noted and illnesses were divided into acute (less than 14 days), persistent (14 days or
more), and dysenteric (bloody diarrhoea, irrespective of duration).
In all cases, age, sex, HIV status and CD4 count (if HIV seropositive) were recorded for
each participant at the time of each biopsy. HIV testing was carried out using Capillus rapid
kits and CD4 count using FACScount (Beckton Dickinson). We measured nutritional status
by measuring height, weight, and mid upper arm circumference (MUAC), and body mass
index (BMI) calculated in the usual way.
Analysis of intestinal biopsies
Four biopsies were collected using standard biopsy forceps and placed in sterile Cryovials
(Nalgene, Rochester, NY) before immersion in liquid nitrogen and storage at −80°C. Within
6 months two biopsies were retrieved and digested together in TRI Reagent (Sigma-Aldrich,
Gillingham, Dorset, UK), followed by phenol-chloroform-isopropanol extraction, using
standard procedures, and PCR for the α-defensins. Where the initial amplification was
unsatisfactory, and for amplification of β-defensins, LL-37, and housekeeping genes, the
remaining biopsies were used. Total RNA was reverse transcribed to cDNA using reverse
transcriptase (Promega, Southampton, UK). mRNA for human α defensins 5 and 6 (HD5,
HD6), human β-defensins 1 and 2 (hBD1, hBD2), LL-37 and interleukin (IL)-8 were
quantified by real time PCR using the primers and conditions listed at http://
www.qmul.ac.uk/Profiles/Digestive%20Diseases/Kelly%20Paul.htm, with SyBR-Green as
fluorophore and using a Corbett RotorGene 3000 thermal cycler (Corbett Research, Sydney,
Australia). In order to be able to quantify HD5 and HD6 mRNA in absolute terms, each run
included a series of standards which comprised plasmids into which the target sequence of
interest had been cloned [17], and a standard cDNA was included in all runs and used as an
additional reference gene. The standard cDNA was made from RNA extracted from Caco-2
cells treated with 20ng/ml IL-1β (Peprotech, London, UK). For hBD1, hBD2 and LL-37, the
invariant epithelial marker cytokeratin-19 (CK-19) was used as a reference marker of
epithelial cell mass and relative quantification performed; for LL-37 GAPDH was also used.
In preliminary experiments, α1-anti-trypsin was used as an invariant Paneth cell marker [17]
to confirm that changes in HD5 and HD6 expression were not due to changes in Paneth cell
mass (data not shown). Where any unsatisfactory results were obtained (impure RNA
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preparation, low yield, poor amplification, poor melt curves), the whole protocol was
repeated beginning with the reserve biopsies.
Paneth cell granule abnormalities
We have previously described Paneth cell granule depletion in Zambian adults which
appeared to be associated with low serum zinc concentrations [23]. During endoscopy, two
additional biopsies were collected (making 6 in total) and orientated before fixation as
previously described [24]. We evaluated Paneth cell morphology in 217 satisfactorily-
orientated haematoxylin-eosin stained sections using the same criteria as in the previous
study (i.e. normal, mild granule depletion, severe granule depletion)[23].
Measurement of serum leptin concentration
When it became apparent that there were sex-dependent nutritional interactions with
antimicrobial gene expression, serum leptin and adiponectin concentrations were measured
in sera obtained from blood collected at the time of endoscopy. Leptin and adiponectin were
assayed by ELISA (R&D Systems, Abingdon, UK) according to the manufacturer’s
instructions.
Data analysis
HD5 and HD5 mRNA content was expressed as log number of transcripts per microgram of
total RNA extracted, using standard curves constructed using the plasmid standards. For
hBD1, hBD2 and LL-37, all results were expressed relative to CK-19 and the Standard
cDNA by first subtracting CtSample from CtStandard to derive the variable x and then
subtracting CtRef from CtStandard to derive the variable y, where CtRef is the Ct value of
amplification of the reference gene (CK19), CtStandard is the Ct of the Standard cDNA, and
CtSample is the Ct value of amplification of the gene of interest. The ratio of expression of
the gene of interest to CK-19 was obtained using the formula 2(y-x).
The primary comparison was mRNA of these five genes in scheduled biopsies from
recipients of MM or placebo, and this was analysed using the Kruskal-Wallis test. hBD2
expression was detected in a minority of participants so it was analysed as a categorical
value (either present or absent). In exploratory analysis, sub-groups were analysed by age,
sex, HIV status, CD4 count, and nutritional status. For the diarrhoea samples, the primary
analysis was the difference in mRNA between diarrhoea and convalescent biopsies, and this
difference was compared in MM and placebo recipients using the Kruskal-Wallis test.
Comparison of HD5 across quartiles of BMI was analysed using Cuzick’s non-parametric
trend test. Correlations between nutritional parameters and defensins expression used
Spearman’s rank correlation coefficient. Statistical analysis was carried out using Stata 10
(Stata Corp, College Station, TX).
Sample size calculations were based on results of a previous study of α-defensins [22]
which revealed significant effects in predicting diarrhoea of just under one log transcripts/μg
total RNA for HD5. We estimated that to detect an effect of the size of 0.5 log transcripts/μg
total RNA (from 3.3 to 2.8) with SD of 0.98 with 90% power and 95% confidence would
require 81 in each group for each antimicrobial gene product. The sample size for α-
defensins was much higher than this to ensure that the data were representative and to allow
for sub-group analysis.
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Results
The trial was carried out from September 2003 to December 2006. Demographic and other
characteristics of participants from whom biopsies were obtained are given in Table 1, and
their flow through the trial is shown in Figure 1.
Impact of MM supplementation on gene expression in scheduled samples
A total of 511 scheduled sets of biopsies were taken from 287 participants. After the cross-
over, 130 of these participants were still in the trial and 165 of these biopsies were taken
after the cross-over. mRNA was assayed by real time RT-PCR for HD5 (n=476), HD6
(n=479), hBD1 (n=136), hBD2 (n=197), and the cathelicidin LL-37 (n=196). Fewer results
were obtained for β-defensins and LL-37 as cDNA was used up by the PCRs performed.
The α-defensins and hBD1 were constitutively expressed but hBD2 was expressed in only
10% of biopsies and LL-37 in 40%. Interleukin (IL)-8 mRNA was measured to determine if
intestinal inflammation explained the expression of hBD2, which is an inducible defensin,
but no difference was found between biopsies in which hBD2 was detected and those in
which it was not (P=0.41). In contrast, IL-8 mRNA (relative to the cytokeratin CK-19) was
higher (median 7989, IQR 7224-8303) in 70 biopsies in which LL-37 was found than in 110
biopsies in which LL-37 was not detected (7738, 7222-7960; P=0.001). Overall, there was
no statistically significant difference between HD5, HD6, hBD1, hBD2, or LL-37 in the
MM group compared to placebo (Table 2). When comparing the change in α-defensin
expression at the cross-over, there was no difference by treatment allocation (P=0.29 for
HD5, P=0.35 for HD6). Neither was there any difference by HIV status (data not shown). In
this study there was no correlation between the expression of HD5 and probability of
diarrhoea in the 2 month period of follow up after the biopsy was taken.
Sub-group analysis of antimicrobial gene expression
There was no difference in gene expression by HIV status, CD4 count or age, but there was
evidence of an effect of sex and body mass. HD5 expression (median, IQR log transcript
number per μg total RNA) was lower (P=0.04) in 280 biopsies from women (3.2, 2.5-3.9)
than in 196 from men (3.5, 2.7-4.1). hBD1 mRNA (relative to CK-19 mRNA) was higher
(9747, 9260-10057) in 19 biopsies from participants with BMI<18.5kg/m2 than in 110
biopsies from participants with higher BMI (8939, 0-9846; P=0.03).
Analysis of sub-groups as defined above revealed two sub-groups in which there was an
effect of treatment allocation. The first was an effect on HD5 in participants whose BMI was
18.5kg/m2 or less (Figure 2). The second was an effect on hBD1 mRNA in HIV
seronegative participants: median (IQR) was 9706 (0 – 10229) in 41 participants allocated to
MM compared to 6339 (0-9515) in 36 participants allocated to placebo (P=0.01).
HD5 fell with quartiles of increasing BMI in women and in participants receiving MM, with
the strongest effect in women allocated to MM (P=0.001; Figure 3). Spearman’s rank
correlation coefficients between HD5 or HD6 and BMI or MUAC showed consistent
relationships (Table 3). No such relationships were evident for hBD1, hBD2 or LL-37 (data
not shown).
Adipocytokines have effects on inflammatory responses [25,26] and display sex-dependent
correlations with nutritional status in this [27] and other populations. We looked for
evidence that they might signal body mass to Paneth cells by measuring concentrations in
blood by ELISA. Serum leptin (median, IQR) was 11.3 (.6-27.4) ng/ml in 162 women and
2.5 (1.3-4.0) ng/ml in 79 men (P=0.0001). Serum adiponectin was 14.2 (10.2-21.1) mg/ml in
83 women compared to 10.8 (5.6-24.3) in 48 men (P=0.19). Serum leptin showed strong
correlations with BMI and MUAC, especially in women (ρ=0.71 and 0.69 respectively;
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P<0.0001 for both) as expected, but the relationship between adiponectin and BMI was only
just significant (ρ=-0.26; P<0.02) and there was no correlation with MUAC. While HD5 and
BMI were correlated in women taking micronutrients, the correlation was weaker for leptin
and there was no correlation for adiponectin (Table 3). Furthermore, in multiple linear
regression, leptin was not significantly correlated with HD5 if BMI was also included in the
model. We conclude that neither leptin nor adiponectin explain the correlations between
nutritional status and α-defensin gene expression.
Paneth cell granule depletion
Evidence of Paneth cell granule depletion was looked for in 217 biopsies. Mild depletion
was seen in 30 participants allocated to receive MM supplements and 36 allocated to
placebo; severe depletion was seen in 22 and 12 respectively. None of these differences
were statistically significant even after Mantel-Haenszel stratification for low BMI.
Impact of MM supplementation on gene expression changes during diarrhoeal disease
We also studied HD5 and HD6 expression in the dynamic circumstances before, during or
after diarrhoeal disease in 54 participants: 34 with acute diarrhoea, 15 with persistent
diarrhoea and 5 with asymptomatic infections (3 Cryptosporidium parvum, 1 Salmonella
enterica serovar typhimurium, 1 Strongyloides stercoralis). Suppression of HD5 or HD6 by
intestinal infection was inferred when the value during diarrhoea was >0.5 log less than the
pre-post diarrhoea sample. Suppression of HD5 was observed during 44% of episodes and
suppression of HD6 in 46% of episodes. During diarrhoea, HD5 expression was reduced by
0.8 log transcripts/μg total RNA in placebo recipients (P=0.02) but not in MM recipients or
after the cross-over (Figure 4).
Discussion
In tropical populations, where micronutrient deficiencies are widespread and infectious
diseases are common, understanding interactions between nutrition and host defence could
be of great importance. We set out to test the hypothesis that micronutrient supplementation
can bolster innate defence of the intestinal mucosa. Our trial demonstrates that micronutrient
supplementation does not augment expression of antimicrobial genes in the gut, at least in
the dose range examined. Thus, the population difference we have previously reported
between European and African populations [14] is unlikely to be explained by borderline
micronutrient deficiencies, unless adults in this population for some reason require higher
intakes to achieve ‘healthy’ micronutrient balance (which might in fact be the case [18]).
However, in malnourished adults HD5 was up-regulated by the supplementation. Although
this is a subgroup analysis, the study cohort included 48 malnourished adults, a not
insubstantial number. The opportunity for subgroup analysis arises from the large sample
size in this study, and it is precisely the subgroup in which one would have expected, a
priori, the benefit of micronutrients to matter. Most importantly, our data also suggest that
defensin expression is reduced during acute infectious diarrhoea, and that MM
supplementation can reduce the impact of pathogens.
HD5 and HD6 mRNA levels were correlated with nutritional status, which is of interest
because HD5 is probably the most abundant of the small intestinal antimicrobial peptides
[17]. No such correlations were observed for the other genes analyzed but the power of the
correlation analysis for other mRNAs is limited as fewer samples were available for
quantification. The observed sex difference was unexpected. Our findings suggest that there
are sex-dependent, possibly endocrine, determinants of HD5 and HD6 expression. We have
previously found that in AIDS patients in Zambia, serum leptin does not correlate with fat
mass in men but does in women [27]. In the light of the findings reported here, we re-
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analysed data from two previous community studies [18,28] and found that the incidence of
diarrhoea was higher in women. We had previously reported [22] that lower HD5 expression
predicts diarrhoea, although in this study we could not confirm this when analysed in the
same way as in the earlier report [22]. The lower HD5 expression in women, who also had
higher diarrhoea incidence, may provide some evidence that HD5 contributes to host
defence against diarrhoea-causing pathogens. Recent data suggest that the impact of zinc on
mortality in children in Tanzania is sex-dependent [29,30] and evidence from Guinea-Bissau
indicates that the response to vitamin A supplementation may also be sex-dependent [31].
Further work is needed to determine the mechanism of the sex-dependent relationship
between host defence and nutritional status. We did not find evidence that leptin or
adiponectin correlate as closely with HD5 gene expression as does BMI, so we conclude that
these molecules are unlikely to be the molecular signals of body composition to the Paneth
cell. It has recently become apparent that leptin and adiponectin are also synthesised by
Paneth cells [32] but their biological function when secreted by the Paneth cell is as yet
unexplained.
The level of HD5 and HD6 gene expression was expressed in absolute terms as mRNA
transcripts per μg total RNA, and was considerably lower than in published studies from our
and other groups [14,17]. We cannot explain this difference which arose when we changed
from competitive RT-PCR [14] to real time RT-PCR. We have re-calibrated the plasmid
standards, which were used throughout, and a cDNA control was used to ensure consistency
between runs over the 3.3 years of the study, so we are confident that our data are internally
consistent and the differences and correlations we found are meaningful.
LL-37 is constitutively expressed in the large but not the small intestine. Here, its expression
was detected in a minority of small intestinal biopsies. As the MM supplement includes
vitamin D we looked for any evidence of induction of LL-37 in the MM group, but this was
not seen. Vitamin D up-regulates LL-37 transcription in biliary epithelial cells in culture
[33], but this effect has not been investigated in small intestinal epithelial cells. In
colonocytes, butyrate induces expression of both the vitamin D receptor [34] and LL-37
[35], so on a high-carbohydrate African diet (with ample butyrate generation in the colon)
we might have expected LL-37 expression to be responsive to vitamin D, but it is unknown
if these transcriptional effects operate over long periods of time. LL-37 expression was
associated with higher IL-8 expression, suggesting that its expression is partially induced by
inflammatory signals. As LL-37 is also expressed by neutrophils, it is possible that this is
due to neutrophil recruitment by IL-8. This aspect of LL-37 regulation needs further
investigation in vitro and in vivo. Work by other groups [36] led us to expect that hBD2 and
IL-8 expression would be associated, but hBD2 was expressed in only 10% of the biopsies
we analysed and was unrelated to IL-8 expression.
HIV seroprevalence is around 22-30% in urban Zambia [37], and a high proportion of our
participants were infected with it. However it does not seem to have an impact on
antimicrobial peptide expression in the intestine. This lack of effect of HIV is entirely
consistent with our previous findings [22], and it offers the hope that it might be possible to
improve host defence in the gut through antimicrobial peptides even when cellular immunity
is severely impaired.
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Figure 1.
Flow of participants through the trial. Of the 500 participants randomised, 287 underwent
endoscopy at one time or another. Others were designated to participate in a parallel sub-
study of permeability which will be reported elsewhere, or were ineligible for either
investigation (for example, pregnancy or having taken non-steroidal anti-inflammatory
drugs).
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Figure 2.
Effect of multiple micronutrient supplementation in malnourished (BMI<18.5kg/m2) adults
allocated to MM (n=18) or placebo (n=30), and in adults of normal (BMI>18.5kg/m2) body
mass index allocated to MM (n=219) or placebo (n=209). Bars show median values and
shaded boxes the interquartile range (IQR). P values refer to Kruskal-Wallis test.
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Figure 3.
HD5 expression (median, IQR) by quartiles of BMI in women allocated to micronutrient
supplementation only. As BMI increased, HD5 mRNA decreased (P<0.001 using Cusick’s
non-parametric test for trend), prompting an analysis of adipocytokine concentrations in
serum.
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Figure 4.
Changes in HD5 expression (median change, IQR, range) during diarrhoea, shown relative
to the convalescent biopsy (see Methods) expressed so that a negative value means down-
regulation during the episode of diarrhoea. In patients allocated to placebo there was a
significant down-regulation during diarrhoea, but this was not seen in patients allocated to
micronutrients (MM), nor to those allocated to placebo after the cross-over. This could be
due to carry-over of a protective effect despite the 3 months washout.
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Table 3
Correlations between a-defensin expression and nutritional measures
Spearman’s rank correlation
coefficient
HD5 P HD6 P
Correlation with BMI
Women only (n=249) −0.21 0.0007 −0.20 0.001
MM only (n=202) −0.26 0.0002 −0.17 0.01
Women taking MM (n=116) −0.32 0.0002 −0.30 0.0005
Correlation with MUAC
Women only (n=248) −0.24 0.0001 −0.16 0.02
MM only (n=203) −0.29 0.0001 −0.12 0.14
Women taking MM (n=134) −0.35 <0.0001 −0.23 0.007
Correlation with serum leptin
Women only (n=154) −0.17 0.04 −0.20 0.01
MM only (n=109) −0.12 0.19 −0.07 0.47
Women taking MM (n=80) −0.20 0.07 −0.22 0.05
Correlation with serum adiponectin
Women only (n=80) 0.13 0.24 0.003 0.98
MM only (n=62) 0.13 0.32 0.13 0.32
Women taking MM (n=44) 0.14 0.38 0.06 0.70
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